Phakic lens holds promise for correcting high myopia, hyperopia


Philadelphia-Patients with high myopia and high hyperopia seemed to have a good response to the implantation of the Phakic Refractive Lens (PRL, Medennium Inc.), according to Kenneth J. Hoffer, MD, who reported on the phase III trial for myopia and the phase II trial for hyperopia during the American Society of Cataract and Refractive Surgery meeting here.

Related Videos
Jennifer Lim, MD, FARVO
Related Content
© 2023 MJH Life Sciences

All rights reserved.